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The objective of this study was to assess the prevalence, antibiogram, and
related genes of carbapenem-resistant Klebsiella pneumoniae (CRKP) among hospital
environment samples. A total of 250 samples were taken from different surfaces and
medical devices of three hospitals in Isfahan, Iran. All samples were cultured and
K. pneumoniae strains were identiﬁed by conventional microbiological methods and
polymerase chain reaction (PCR). Antibiogram of isolates was performed by disk
diffusion method and production of carbapenemases and metallo-β-lactamases
(MBLs) was conﬁrmed using modiﬁed Hodge test and E-test, respectively. Molecular
detection of the related genes was carried out by PCR. Overall, 37 (14.8%)
K. pneumoniae strains were isolated, of which 34 (91.9%) strains were resistant to
carbapenems. Twenty-eight (82.4%) isolates were positive for carbapenemases and
seven (20.6%) isolates were phenotypically MBL producers. The results of PCR
showed that the prevalence of blaOXA-48, blaNDM, blaIMP, blaSHV, blaCTX-M, blaTEM,
and class 1 integron among CRKP isolates was 70.6%, 52.9%, 2.9%, 100%, 82.4%,
55.9%, and 76.5%, respectively. However, blaKPC, blaGES, blaIMI, blaVIM, and class 2
integron were not detected in any of the isolates. This study showed that the
environment of our hospitals is contaminated with CRKP and it emphasizes the
importance of using standard methods for infection control.
Keywords: carbapenem-resistant Klebsiella pneumoniae, CRKP, OXA-48,
NDM, hospital environment
Introduction
The emergence and dissemination of carbapenem-resistant Klebsiella
pneumoniae (CRKP) in hospitals is a great concern for healthcare systems
worldwide [1]. CRKP is resistant to almost all antimicrobial agents, and
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outbreaks caused by this pathogen are associated with considerable morbidity
and mortality [2]. Infected patients with CRKP can be a source of its spread in the
hospital and can transfer it to other patients or even personnel [3]. Probably, the
environment surrounding these patients is contaminated with these organisms and
is responsible for disseminating directly or indirectly [4, 5]. Due to the vulnerability
of patients in intensive care unit (ICU), the presence of CRKP strains in the
environment of this ward is very important in terms of infection control [6, 7].
Undoubtedly, knowing the status of hospital environment contamination with
CRKP and the use of effective methods for disinfecting the environment and
medical devices from these organisms can help control infection in ICUs. Since
there has not been a study on the prevalence of these organisms in hospital
environments in Iran, this study aims to evaluate the prevalence, antibiotic
resistance pattern, and related genes of CRKP among hospital environment samples
in the ICUs of three hospitals of Isfahan, Iran.
Materials and Methods
Bacterial isolates
During a 3-month period, from May to July 2017, bacterial strains were
isolated from 250 surface samples in the ICUs of three hospitals (Alzahra, Imam
Musa Kazim, and Khorshid) of Isfahan, Iran. All samples were taken using swabs
from different surfaces and medical devices including hospital beds, ventilators,
aerators, suctions, monitors, stethoscopes, sphygmomanometer cuffs, pulse ox-
imeter probes, chest leads, infusion pumps, oxygen bubblers, oxygen masks,
cabinets, sinks, water taps, walls, phone handsets, and washing liquid. For
sampling, sterile cotton-tipped applicators were moistened in 2 ml of sterile
normal saline, rolled several times over a surface area (∼20 cm2), immersed in
tryptic soy broth medium, vortexed gently, and aerobically incubated at 37 °C
overnight. Then, tubes with turbidity were subcultured in blood agar and eosin
methylene blue agar plates. After 24 h of incubation at 37 °C, all lactose-positive
colonies were examined using conventional microbiological methods such as
Gram-staining and biochemical (oxidase, sugar fermentation, IMViC, Kliger’s
iron agar, nitrate reduction, motility, etc.) tests [8]. To conﬁrm the species, we
carried out a polymerase chain reaction (PCR) detection based on the 16S–23S
internal transcribed spacer sequence of K. pneumoniae [9]. This study was
evaluated and approved by the ethics committee of Isfahan University of Medical
Sciences (project no.: 395891).
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Antibiotic susceptibility testing
Antibiotic susceptibility of isolates was determined by Kirby–Bauer’s disk
diffusion method, according to Clinical Laboratory Standard Institute (CLSI)
recommendations [10]. For this end, we used 18 antibiotic disks (MAST, UK
and Lioﬁlchem, Italy), including imipenem (10 μg), meropenem (10 μg),
ertapenem (10 μg), gentamicin (10 μg), ceftaroline (30 μg), piperacillin/
tazobactam (100/10 μg), cefazolin (30 μg), cefuroxime (30 μg), ceftazidime
(30 μg), cefepime (30 μg), cefoxitin (30 μg), ciproﬂoxacin (5 μg), trimethoprim/
sulfamethoxazole (1.25/23.75 μg), tigecycline (15 μg), aztreonam (30 μg),
amoxicillin/clavulanic acid (20/10 μg), chloramphenicol (30 μg), and tetracy-
cline (30 μg). Escherichia coli ATCC 25922 was used for quality control of disk
diffusion method [10].
Carbapenemase and metallo-β-lactamase (MBL) screening assays
Carbapenemase activity was determined using the modiﬁed Hodge test
(MHT) by ertapenem disk (MAST), according to CLSI guidelines [10]. To detect
MBL activity, E-test method using strips containing meropenem/meropenem+
EDTA (Lioﬁlchem) was performed based on manufacturer’s instructions.
PCR for the detection of antibiotic resistance genes
DNA was extracted using the boiling method and used as a template
for PCR [11]. To detect antibiotic-resistant genetic elements, including
blaKPC, blaGES, blaIMI, blaVIM, blaIMP, blaNDM, blaOXA-48, blaSHV, blaTEM,
and blaCTX-M as well as class 1 and 2 integrons, separate PCR reactions were
performed. The list of all target genes and corresponding primers is presented in
Table I [12–19]. PCR was performed using commercially available PCR Master
Mix (Ampliqon, Denmark), according to the manufacturer’s instructions. Brief-
ly, 1 μl of template DNA (∼100 ng/μl), 1 μl of each primer (10 pmoles/μl), and
9.5 μl of DNase-free distilled water were added to 12.5 μl of Master Mix in a
ﬁnal volume of 25 μl. The cycling conditions consisted of a 5-min initial
denaturation step at 95 °C, followed by 35 cycles of denaturation at 95 °C for
30 s, annealing for 45 s at primer-speciﬁc temperatures (Table I), extension at
72 °C for 1 min, and a ﬁnal extension step at 72 °C for 10 min. PCR products
were resolved by standard electrophoresis on 1.5% agarose gel containing DNA
safe stain.
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Results
Bacterial isolates
Table II demonstrates the relative frequency of CRKP strains isolated from
hospital surfaces and medical devices. Overall, 250 samples were cultured, of
which 28 (11.2%) samples were negative and 37 (14.8%) samples were contami-
nated by K. pneumoniae strains.
Antibiotic susceptibility testing
Table III demonstrates the results of antibiotic susceptibility testing in hospital
environment isolates. The highest resistance rate was obtained for ertapenem,
cefepime, ceftazidime, ceftaroline, cefuroxime, and cefazolin with 91.9%.
Table I. List of primers, expected amplicon size, and annealing temperatures
Target






blaKPC F: GATACCACGTTCCGTCTGG 58 246 [12]
R: GCAGGTTCCGGTTTTGTCTC
blaGES F: GTTTTGCAATGTGCTCAACG 53 371 [13]
R: TGCCATAGCAATAGGCGTAG
blaIMI F: ATGTCATTAGGTGATATGGC 50 879 [14]
R: GCATAATCATTTGCCGTACC
blaVIM F: TTTGGTCGCATATCGCAACG 66 500 [15]
R: CCATTCAGCCAGATCGGCAT
blaIMP F: GTTTATGTTCATACATCG 45 440 [15]
R: GGTTTAACAAAACAACCAC
blaNDM F: GGGCAGTCGCTTCCAACGGT 52 475 [16]
R: GTAGTGCTCAGTGTCGGCAT
blaOXA-48 F: GCGTGGTTAAGGATGAACAC 60 438 [17]
R: CATCAAGTTCAACCCAACCG
blaSHV F: ATGCGTTATATTCGCCTGTG 60 753 [15]
R: TGCTTTGTTATTCGGGCCAA
blaTEM F: AAACGCTGGTGAAAGTA 45 752 [15]
R: AGCGATCTGTCTAT
blaCTX-M F: TTTGCGATGTGCAGTACCAGTAA 51 544 [18]
R: CGATATCGTTGGTGGTGCCATA
intI1 F: GGTCAAGGATCTGGATTTCG 52 484 [19]
R: ACATGCGTGTAAATCATCGTC
intI2 F: CACGGATATGCGACAAAAAGGT 54 789 [19]
R: GTAGCAAACGAGTGACGAAATG
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Hospital bed 61 60 (98.4) 10 (16.7) 10 (100.0)
Ventilator 47 42 (89.4) 6 (14.3) 5 (83.3)
Sphygmomanometer
cuff
25 25 (100.0) 10 (40.0) 9 (90.0)
Sink 21 17 (80.9) 3 (17.6) 2 (66.7)
Oxygen bubbler 20 13 (65.0) 1 (7.7) 1 (100.0)
Wall 16 13 (81.3) 1 (7.7) 1 (100.0)
Suction 10 7 (70.0) 2 (28.6) 2 (100.0)
Pulse oximeter probe 9 9 (100.0) 2 (22.2) 2 (100.0)
Cabinet 8 6 (75.0) 0 (0.0) 0 (0.0)
Water tap 6 5 (83.3) 0 (0.0) 0 (0.0)
Monitor 5 5 (100.0) 0 (0.0) 0 (0.0)
Aerator 4 2 (50.0) 0 (0.0) 0 (0.0)
Infusion pump 4 4 (100.0) 0 (0.0) 0 (0.0)
Stethoscope 4 4 (100.0) 0 (0.0) 0 (0.0)
Chest lead 3 3 (100.0) 1 (33.3) 1 (100.0)
Oxygen mask 3 3 (100.0) 1 (33.3) 1 (100.0)
Phone handset 3 3 (100.0) 0 (0.0) 0 (0.0)
Washing liquid 1 0 (0.0) 0 (0.0) 0 (0.0)
Total 250 222 (88.8) 37 (16.7) 34 (91.9)
Note: CRKP: carbapenem-resistant Klebsiella pneumonia.
Table III. Antibiotic susceptibility of K. pneumoniae isolates (n= 37)
Antibiotic Susceptible [n (%)] Intermediate [n (%)] Resistant [n (%)]
Imipenem 10 (27.0) 3 (8.1) 24 (64.9)
Meropenem 3 (8.1) 1 (2.7) 33 (89.2)
Ertapenem 3 (8.1) 0 (0.0) 34 (91.9)
Gentamicin 7 (18.9) 0 (0.0) 30 (81.1)
Ceftaroline 3 (8.1) 0 (0.0) 34 (91.9)
Piperacillin/tazobactam 4 (10.8) 0 (0.0) 33 (89.2)
Cefazolin 3 (8.1) 0 (0.0) 34 (91.9)
Cefuroxime 3 (8.1) 0 (0.0) 34 (91.9)
Ceftazidime 3 (8.1) 0 (0.0) 34 (91.9)
Cefepime 3 (8.1) 0 (0.0) 34 (91.9)
Cefoxitin 5 (13.5) 5 (13.5) 27 (73.0)
Ciproﬂoxacin 4 (10.8) 0 (0.0) 33 (89.2)
Trimethoprim/sulfamethoxazole 13 (35.1) 1 (2.7) 23 (62.2)
Tigecycline 19 (51.4) 7 (18.9) 11 (29.7)
Aztreonam 5 (13.5) 0 (0.0) 32 (86.5)
Amoxicillin/clavulanic acid 3 (8.1) 1 (2.7) 33 (89.2)
Chloramphenicol 14 (37.8) 8 (21.6) 15 (40.6)
Tetracycline 11 (29.7) 4 (10.8) 22 (59.5)
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Tigecycline was the most effective antibiotic with 51.4% susceptibility rate followed
by chloramphenicol (37.8%) and tetracycline (29.7%). Among the carbapenems, the
highest and the lowest resistance rates were detected for ertapenem (91.9%) and
imipenem (64.9%), respectively. Overall, 34 (91.9%) isolates were resistant to
carbapenems.
Carbapenemase and MBL screening assays
The results of MHT on 34 isolates with resistance to carbapenems showed
that 28 (82.4%) isolates were positive and 6 (17.6%) isolates were negative. In
addition, phenotypic MBL production testing on these isolates identiﬁed 7
(20.6%) isolates as positive, 8 (23.5%) isolates as negative, and 19 (55.9%)
isolates with non-determinable results.
PCR for the detection of antibiotic resistance genes
All CRKP isolates were examined by PCR for the presence of the special
antibiotic resistance genetic elements. Twenty-four (70.6%) isolates harbored
blaOXA-48, 18 (52.9%) isolates were positive for the blaNDM, and blaIMP was
detected in 1 (2.9%) isolate. Moreover, nine (26.5%) isolates had both blaNDM and
blaOXA-48, simultaneously. Extended-spectrum β-lactamases (ESBLs)-encoding
genes including blaSHV, blaCTX-M, and blaTEM were identiﬁed in 100%, 82.4%,
and 55.9% isolates, respectively. In addition, 16 (47.1%) isolates had blaSHV,
blaCTX-M, and blaTEM genes, concurrently. Three (8.8%) isolates were positive for
the presence of blaOXA-48, blaNDM, blaSHV, blaCTX-M, and blaTEM, together.
Nevertheless, the results of PCR were negative for blaKPC, blaGES, blaIMI, and
blaVIM. Furthermore, 26 (76.5%) isolates harbored class 1 integron, but class 2
integron was not detected in any of the isolates.
Discussion
In this study, we documented the existence of CRKP in the hospital
environment and the surfaces of medical devices. As we know that CRKP can
survive for more than 2 weeks on dry surfaces [20], this ﬁnding reveals the role
of the hospital environment as a source of the transmission of CRKP to the
hospitalized patients. In this study, the isolation rate of K. pneumoniae from
hospital environment samples was 14.8%. In several studies conducted in Iran
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that used the same method (wet sterile swab) for sampling, the isolation rate
of K. pneumoniae from hospital environment samples was less than ours:
Mehraban et al. (0.4%) [21], Ayatollahi et al. (4.5%) [22], Ekrami et al.
(4.7%) [23], and Zazouli et al. (5%) [24]. This difference can be due to the
difference in the level of environment contamination in the hospitals studied, the
sampling ward, the sampling time, the sampling site, and cultivation method.
Among the medical devices and surfaces, the highest level of relative contami-
nation with K. pneumoniae was detected in sphygmomanometer cuffs (40%),
followed by chest leads (33.3%), oxygen masks (33.3%), suctions (28.6%),
pulse oximeter probes (22.2%), sinks (17.6%), hospital beds (16.7%), ventilators
(14.3%), oxygen bubblers (7.7%), and walls (7.7%). CRKP strains were isolated
from 10 of the 18 sites sampled: hospital beds, ventilators, sphygmomanometer
cuffs, sinks, suctions, pulse oximeter probes, oxygen bubbler, wall, chest lead,
and oxygen mask. In the study by Lerner et al. [1] in Israel, they have identiﬁed
carbapenem-resistant Enterobacteriaceae strains in only 5 of the 14 sites
sampled. About the antibiogram results of K. pneumoniae isolates, the highest
resistance rate was observed for β-lactam antibiotics; however, the lowest
resistance rate was identiﬁed for tigecycline. In this regard, the results of this
study are consistent with the other two studies conducted on clinical isolates in
the hospitals studied [25, 26]. In this study, blaOXA-48 was the most prevalent
carbapenemase detected, followed by blaNDM. Similarly, our ﬁndings are in
parallel with the studies of Solgi et al. [25, 26] in our region. We detected blaIMP
in one CRKP isolate. This isolate was obtained from a ventilator in the ICU of
Alzahra hospital and was resistant to all the aforementioned antibiotics except
gentamicin and chloramphenicol. Moreover, this isolate carried blaOXA-48,
blaCTX-M, blaTEM, blaSHV, and class 1 integron, simultaneously. To the best
of our knowledge, this is the second report of blaIMP-harbored K. pneumoniae
from Iran after Khorvash et al. [27]. This study showed a high prevalence of
ESBLs-encoding genes (blaSHV, blaCTX-M, and blaTEM) among CRKP isolates,
which is consistent with other studies conducted in Isfahan [25, 26] and Iran
[28–30]. However, we have not detected blaKPC, blaGES, blaIMI, and blaVIM
among CRKP isolates. In this regard, studies that were previously carried out in
Isfahan have not been able to identify these genes [26, 31, 32]. On the contrary,
Khorvash et al. [27] in their study identiﬁed blaVIM in 10.3% of CRKP isolates
from clinical isolates of Alzahra hospital. In conclusion, this study showed
the existence of CRKP isolates in the patients’ surroundings in the ICUs of
our hospitals. It emphasizes the importance of using standard methods of
infection control for disinfecting surfaces of medical devices and hospital
environment.
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